Omr-IgG-am

· National Institutes of Health Clinical Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Omr-IgG-am, covering 2017-07-02 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Omr-IgG-am(Trademark) for Treating Patients With or at High Risk for West Nile Virus Disease [Phase 2]